相关实验视频

Updated: May 20, 2025

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care

Published on: February 16, 2015

调节瘤生态系统的机会,使质母细胞瘤免疫疗法成功

Mariko Takahashi^1,2, Darina Mukhamejanova^2,3,4, Himani Jasewicz²

¹Department of Pharmaceutical Sciences, University of Michigan, Ann Arbor, Michigan, USA.

|March 24, 2025

概括

质母细胞瘤 (GBM) 免疫疗法由于其复杂的瘤微环境而无效. 新的战略重点是针对GBM.

科学领域:

神经瘤学神经瘤学
免疫学免疫学免疫学
癌症生物学癌症生物学

背景情况:

质母细胞瘤 (GBM) 仍然是一个重大挑战,许多临床试验未能产生有效的治疗方法.
由于复杂和免疫抑制瘤微环境,目前的免疫疗法对GBM进行斗争.
了解中枢神经系统 (CNS) 免疫的进展为GBM治疗提供了新的途径.

研究的目的:

系统地审查开发有效的质母细胞瘤免疫疗法的挑战和机遇.
探索克服免疫抑制性GBM微环境的新策略.
讨论将中枢神经系统免疫的洞察力转化为GBM的临床应用.

主要方法:

文献综述和关于GBM免疫学和微环境的最新发现的综合.
分析当前免疫疗法方法及其在GBM中的局限性.
讨论在GBM中调节瘤-免疫-肌相互作用的新兴策略.

主要成果:

GBM 微环境对有效的免疫疗法构成重大障碍.
准多个抗原和识别新的免疫抑制点至关重要.
了解利基特异性免疫细胞功能是调节瘤与免疫相互作用的关键.

结论:

对GBM免疫系统的全面了解对于治疗成功至关重要.
新型免疫疗法策略必须解决瘤异质性和免疫抑制.
从中枢神经系统免疫中翻译的见解对未来的GBM治疗有希望.

更多相关视频

Isolation and Flow Cytometric Analysis of Glioma-infiltrating Peripheral Blood Mononuclear Cells

Isolation and Flow Cytometric Analysis of Glioma-infiltrating Peripheral Blood Mononuclear Cells

Published on: November 28, 2015

Isolation and Purification of Fungal β-Glucan as an Immunotherapy Strategy for Glioblastoma

Isolation and Purification of Fungal β-Glucan as an Immunotherapy Strategy for Glioblastoma

Published on: June 2, 2023

相关概念视频

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

The Tumor Microenvironment

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...